ARTICLE | Financial News
SangStat down on restructuring news
October 17, 2000 7:00 AM UTC
SANG was off $2.50 (21 percent) to $9.50 on Tuesday following Monday's announcement after market close that the company terminated all clinical programs for its SangCya Oral Solution formulation of cy...